Renin-angiotensin-aldosterone system-blocker-induced angioedema Advocacy Hub | UniteRare

At a Glance

Live from database

💰

2Open funds

Regulatory Watchboard

2 events

Jun 2017

Haegarda: FDA approved

For routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients.

FDAcompleted

Oct 2009

Berinert: FDA approved

Treatment of acute attacks of hereditary angioedema.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance2

Haegarda

CSL Behring LLC

OpenContact for details

Berinert

CSL Behring LLC

OpenContact for details

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Renin-angiotensin-aldosterone system-blocker-induced angioedema.
Search all trials →

Search clinical trials for Renin-angiotensin-aldosterone system-blocker-induced angioedema →

Recent News & Research

No recent news articles indexed yet for Renin-angiotensin-aldosterone system-blocker-induced angioedema.
Search PubMed for Renin-angiotensin-aldosterone system-blocker-induced angioedema →

Browse all Renin-angiotensin-aldosterone system-blocker-induced angioedema news →

Specialist Network

No specialists currently listed for Renin-angiotensin-aldosterone system-blocker-induced angioedema.

View all Renin-angiotensin-aldosterone system-blocker-induced angioedema specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰